Our findings indicate that AR mediates its anti-T2DM effects through multi-component regulation of critical metabolic and inflammatory signalling hubs, with particular importance placed on the PI3K-Akt and AGE-RAGE pathways as key therapeutic nodes. Here, AKT1 is linked to type 2 diabetes mellitus.